Doyle Janeen Noel sold JANX
June 2, 2026 · Form 4 insider transaction
Doyle Janeen Noel sold 4,059 shares of Janux Therapeutics, Inc. at $14.03 per share, a transaction worth $56.9K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Disposed (sell-side)
Shares
4,059
Price
$14.03
Total value
$56.9K
InsiderDoyle Janeen Noel
RoleOfficer
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateJune 2, 2026
Filing dateJune 4, 2026
Shares owned after75,941
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The shares were automatically sold to cover tax withholding obligations associated with the vesting of restricted stock units.; The weighted average sale price for the transaction reported was $14.029 and the range of prices were between $13.96 and $14.03. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.